Biography
Andrea Burden obtained her Bachelor of Science degree in Psychology and a Master of Arts in Criminology at the University of Toronto.
Following her Master’s program Andrea enrolled in a Master of Science in the faculty of pharmaceutical sciences at the University of Toronto, with focus in pharmacoepidemiology (drug safety and effectiveness). Following 18-months in the MSc program, she transferred to the PhD stream where her research focus was on osteoporosis medication adherence.
In 2014, she received a CIHR fellowship (2015-2017) to conduct her postdoctoral research in the Netherlands, where her focus is on diabetes and bone health and rheumatoid arthritis. Since 2018 she is an Assistant Professor at ETH Zurich where she holds the chair in pharmacoepidemiology at the Institute of Pharmaceutical Sciences.
Andrea has experience analysing some of the world’s most prestigious healthcare databases from Canada, the UK, Denmark and the Netherlands.
Her primary research line examines the safety and effectiveness of medications in chronic disease management, with particular focus on the relationship between metabolic (diabetes and obesity) and musculoskeletal (osteoporosis and rheumatoid arthritis) diseases.
List of 5 Best Publications
The association of bariatric surgery and carpal tunnel syndrome: A propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/39173576/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Inpatient opioid prescribing patterns and their effect on rehospitalisations: a nested case-control study using data from a Swiss public acute hospital
https://pubmed.ncbi.nlm.nih.gov/39154328/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Impact of blue-collar vs. white-collar occupations on disease burden in psoriatic arthritis patients: A Swiss clinical quality management in rheumatic diseases cohort study
https://pubmed.ncbi.nlm.nih.gov/39110326/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Opioid exit plans for tapering postoperative pain control in noncancer patients: a systematic review
https://pubmed.ncbi.nlm.nih.gov/39080780/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Musculoskeletal Morphology and Joint Flexibility-Associated Functional Characteristics across Three Time Points during the Menstrual Cycle in Female Contemporary Dancers
https://pubmed.ncbi.nlm.nih.gov/38535418/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease
https://pubmed.ncbi.nlm.nih.gov/38528988/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care
https://pubmed.ncbi.nlm.nih.gov/38408767/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry
https://pubmed.ncbi.nlm.nih.gov/38331859/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications
https://pubmed.ncbi.nlm.nih.gov/38145014/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Sex- and Age Group-Specific Fracture Incidence Rates Trends for Type 1 and 2 Diabetes Mellitus
https://pubmed.ncbi.nlm.nih.gov/38025040/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab
https://pubmed.ncbi.nlm.nih.gov/37802600/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Identification of Medication Prescription Errors and Factors of Clinical Relevance in 314 Hospitalized Patients for Improved Multidimensional Clinical Decision Support Algorithms
https://pubmed.ncbi.nlm.nih.gov/37568322/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register
https://pubmed.ncbi.nlm.nih.gov/37498856/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Design and Execution of Sustainable Decentralized Clinical Trials
https://pubmed.ncbi.nlm.nih.gov/37489911/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Obesity Represents a Persisting Health Issue in Axial Spondyloarthritis, Particularly Affecting Socially Disadvantaged Patients
https://pubmed.ncbi.nlm.nih.gov/37453738/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Patient groups in Rheumatoid arthritis identified by deep learning respond differently to biologic or targeted synthetic DMARDs
https://pubmed.ncbi.nlm.nih.gov/37267387/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414An explorative analysis of pharmacovigilance data of oxytocin and its analogue carbetocin, with a focus on haemodynamic adverse effects
https://pubmed.ncbi.nlm.nih.gov/37162656/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Cancer risk in patients with rheumatoid arthritis treated with janus kinase inhibitors: a nationwide Danish register-based cohort study
https://pubmed.ncbi.nlm.nih.gov/37052534/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data
https://pubmed.ncbi.nlm.nih.gov/36961031/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Site-Specific Fracture Incidence Rates Among Patients With Type 1 Diabetes, Type 2 Diabetes, or Without Diabetes in Denmark (1997-2017)
https://pubmed.ncbi.nlm.nih.gov/36696428/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Identification of polypharmacy patterns in new-users of metformin using the Apriori algorithm: A novel framework for investigating concomitant drug utilization through association rule mining
https://pubmed.ncbi.nlm.nih.gov/36579709/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414The associations between bariatric surgery and hip or knee arthroplasty, and hip or knee osteoarthritis: Propensity score-matched cohort studies
https://pubmed.ncbi.nlm.nih.gov/36475281/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Comorbidity clusters associated with newly treated type 2 diabetes mellitus: a Bayesian nonparametric analysis
https://pubmed.ncbi.nlm.nih.gov/36450743/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort
https://pubmed.ncbi.nlm.nih.gov/36264948/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort
https://pubmed.ncbi.nlm.nih.gov/36115672/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Opioid sales and opioid-related poisonings in Switzerland: A descriptive population-based time-series analysis
https://pubmed.ncbi.nlm.nih.gov/36090669/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
https://pubmed.ncbi.nlm.nih.gov/35842030/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review
https://pubmed.ncbi.nlm.nih.gov/35578134/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection
https://pubmed.ncbi.nlm.nih.gov/35551258/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study
https://pubmed.ncbi.nlm.nih.gov/35531047/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/35370960/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland
https://pubmed.ncbi.nlm.nih.gov/35292498/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Biological Disease-Modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: A Danish Cohort Study
https://pubmed.ncbi.nlm.nih.gov/35134369/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Bone fragility in diabetes: novel concepts and clinical implications
https://pubmed.ncbi.nlm.nih.gov/35101185/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients
https://pubmed.ncbi.nlm.nih.gov/35054090/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
https://pubmed.ncbi.nlm.nih.gov/34975756/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Fracture Patterns in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review of Recent Literature
https://pubmed.ncbi.nlm.nih.gov/34931295/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Observational cross-sectional case study of toxicities of antifungal drugs
https://pubmed.ncbi.nlm.nih.gov/34896339/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
https://pubmed.ncbi.nlm.nih.gov/34888435/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414The association between bariatric surgery and cataract: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34863672/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414The association of bariatric surgery and Dupuytren's disease: a propensity score-matched cohort study
https://pubmed.ncbi.nlm.nih.gov/34851767/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Community Pharmacist-Administered COVID-19 Vaccinations: A Pilot Customer Survey on Satisfaction and Motivation to Get Vaccinated
https://pubmed.ncbi.nlm.nih.gov/34835251/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414External validation of the PAR-Risk Score to assess potentially avoidable hospital readmission risk in internal medicine patients
https://pubmed.ncbi.nlm.nih.gov/34813625/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Increased radiographic progression of distal hand osteoarthritis occurring during biologic DMARD monotherapy for concomitant rheumatoid arthritis
https://pubmed.ncbi.nlm.nih.gov/34702319/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP)
https://pubmed.ncbi.nlm.nih.gov/34640505/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Clinical Relevance of a 16-Gene Pharmacogenetic Panel Test for Medication Management in a Cohort of 135 Patients
https://pubmed.ncbi.nlm.nih.gov/34361984/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland
https://pubmed.ncbi.nlm.nih.gov/34300360/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink
https://pubmed.ncbi.nlm.nih.gov/34255815/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Assessment of minor health disorders with decision tree-based triage in community pharmacies
https://pubmed.ncbi.nlm.nih.gov/34244075/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414Thiazolidinediones and Glucagon-Like Peptide-1 Receptor Agonists and the Risk of Nonalcoholic Fatty Liver Disease: A Cohort Study
https://pubmed.ncbi.nlm.nih.gov/34129693/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1TuHRxU62XQx0jrP-lYrgZ_ZloBWlnW72-au_x_Hwb68-Ow9rk&fc=None&ff=20241016121759&v=2.18.0.post9+e462414